Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software

Launched by PERSEI VIVARIUM · Apr 2, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how effective a remote monitoring program called Caaring® is for patients with heart failure and reduced ejection fraction, which means their hearts aren't pumping blood as well as they should. The main goal is to see if using this software can help patients manage their condition better and reduce the number of times they need to go back to the hospital. To do this, researchers will compare two groups: one group will use the Caaring® platform to check in and manage their health from home, while the other group will continue their usual care without this extra support.

To be eligible for the study, participants must be at least 18 years old, have been diagnosed with heart failure with reduced ejection fraction, and be comfortable using a smartphone. Those who join the trial will continue to receive regular medical care and will be asked to share their health data over a 12-week period. It's important to note that this trial is not yet recruiting participants, and individuals with certain medical conditions or difficulties in communication may not be able to take part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 years or older
• • Patients diagnosed with heart failure with reduced ejection fraction (EFS40%)
• • Patients discharged after an episode of acute heart failure and/or patients who are being followed up after being admitted for heart failure.
• • Patients who extensively use a smartphone.
• • lnformed Consent is obtained from the patient
• Exclusion Criteria:
• • Patients with cognitive ar sensory difficulties or with insufficient command of Spanish who, in the opinion of the investigator, makes it difficult to understand the questions ar the scales, as long as they do not have a legally authorized representative capable of participating in the study.
• • Transient patients in whom it may be anticipated that follow-up will not be completed due to a change of residence.
• • Patients Who are participating at the time of recruitment in any other clinical trial. Participation in observational studies will not be an exclusion criteria.
• • Patients whose main diagnosis is a poorly controlled mental disorders ar other medical illness.
• • Patients with terminal illness and/or in palliative care according to the criteria of the SECPAL (Spanish Society of Palliative Care).
• • lnstitutionalized patients
• • Patients who are pregnant ar breastfeeding.
• • Patients whose inclusion is not considered advisable by the investigator's assessment due to they are under specific follow-up in other hospital units (hemodialysis, transplants, etc.) that require mandatory hospital attendance less frequently than once every two months.